New Zealand markets open in 5 hours 52 minutes

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
40.52-0.14 (-0.34%)
As of 11:08AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 226.34B
Enterprise value 238.48B
Trailing P/E 7.33
Forward P/E 11.72
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.29
Price/book (mrq)2.37
Enterprise value/revenue 2.38
Enterprise value/EBITDA 6.03

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3-22.09%
S&P500 52-week change 3-10.17%
52-week high 356.32
52-week low 339.23
50-day moving average 343.07
200-day moving average 347.22

Share statistics

Avg vol (3-month) 322.88M
Avg vol (10-day) 326.64M
Shares outstanding 55.64B
Implied shares outstanding 6N/A
Float 85.61B
% held by insiders 10.03%
% held by institutions 170.77%
Shares short (27 Feb 2023) 438.49M
Short ratio (27 Feb 2023) 41.69
Short % of float (27 Feb 2023) 40.69%
Short % of shares outstanding (27 Feb 2023) 40.69%
Shares short (prior month 30 Jan 2023) 439.17M

Dividends & splits

Forward annual dividend rate 41.64
Forward annual dividend yield 44.02%
Trailing annual dividend rate 31.60
Trailing annual dividend yield 33.94%
5-year average dividend yield 43.59
Payout ratio 429.25%
Dividend date 302 Mar 2023
Ex-dividend date 425 Jan 2023
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 31.27%
Operating margin (ttm)38.87%

Management effectiveness

Return on assets (ttm)12.87%
Return on equity (ttm)36.22%

Income statement

Revenue (ttm)100.33B
Revenue per share (ttm)17.89
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)66.23B
Net income avi to common (ttm)31.37B
Diluted EPS (ttm)5.47
Quarterly earnings growth (yoy)47.20%

Balance sheet

Total cash (mrq)22.73B
Total cash per share (mrq)4.05
Total debt (mrq)39.38B
Total debt/equity (mrq)41.05
Current ratio (mrq)1.22
Book value per share (mrq)17.03

Cash flow statement

Operating cash flow (ttm)29.27B
Levered free cash flow (ttm)24.96B